No Detail Found!

Vaccines for Prevention of Cervical Cancer

Author(s)
Mahomed Farouk Mahomed Department of Medical Microbiology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia
Abstract
The characteristics of two prophylactic Human Papilloma Virus HPV vaccines and ethical issues related to HPV vaccination are reviewed in this paper. These vaccines have the potential of substantially reducing HPV-related morbidity and mortality, and in particular cervical cancer. The vaccines cannot treat women with current HPV infection or HPVrelated disease. They should be administered before the commencement of sexual activity. The ideal age group is adolescent girls between the ages 9-13. Both vaccines are highly efficacious and immunogenic and induce high levels of serum antibodies after three doses for all vaccine-related HPV types. School-based vaccination is considered as a costeffective method for its delivery. Adequate education of both clinicians and patients is an essential to ensure effective implementation when considering a national vaccination program.
Publication Details
Page(s) 63-65
DOI DOI not available
Published Journal: Pakistan Journal of Medical Research, Volume: 56, Issue: 2, Year: 2017

Request the full text from PASTIC

Keywords
Cervical Cancer, HPV Vaccines, ethical issues.
0

Citations

0

Downloads

31

Views